This growth of the veterinary/animal vaccines market can be attributed to the rising demand for animal products safe for human consumption. In order to minimize the shedding of organisms that induce foodborne illnesses in humans, vaccines are used. The global veterinary vaccines market size was USD 7.73 Billion in 2019 and is expected to reach USD 12.75 Billion by 2027, at a CAGR of 6.9% during the forecast period. The global market is anticipated to expand substantially during the forecast period.
The Global Veterinary Vaccines Market report by Emergen Research is an all-encompassing study of the global Veterinary Vaccines Market. The report serves as a prototype of the highly functional Veterinary Vaccines Market industry. Our market researchers’ panel has performed quantitative and qualitative assessments of the global Veterinary Vaccines Market dynamics in a bid to forecast the global market growth over the forecast period. They have taken into consideration several factors, such as market penetration, pricing structure, product portfolios, end-user industries, and the key market growth drivers and constraints, to endow the readers with a sound understanding of the market. The report provides the reader with a panoramic view of the Veterinary Vaccines Market, supported by key statistical data and industry-verified facts. Hence, it examines the size, share, and volume of the Veterinary Vaccines Market industry in the historical period to forecast the same valuations for the forecast period.
The Veterinary Vaccines Market research report is broadly bifurcated in terms of product type, application spectrum, end-user landscape, and competitive backdrop, which would help readers gain more impactful insights into the different aspects of the market. Under the competitive outlook, the report’s authors have analyzed the financial standing of the leading companies operating across this industry. The gross profits, revenue shares, sales volume, manufacturing costs, and the individual growth rates of these companies have also been ascertained in this section. Our team has accurately predicted the future market scope of the new entrants and established competitors using several analytical tools, such as Porter’s Five Forces Analysis, SWOT analysis, and investment assessment.
Read [email protected]
Eli Lilly and Company
Phibro Animal Health Corporation
Elanco Animal Health Incorporated
Aptimmune Biologics, Inc.
Dechra Pharmaceuticals PLC
Laboratorios HIPRA, S.A.
Key Highlights of Report
In January 2020, Automazioni VX, Inc. entered into a cooperative agreement with Merck Animal Health, a division of Merck KGaA. The collaboration was aimed to launch Innoject Pro, a uniquely developed technology for subcutaneous injection vaccination of chicken. The technology can be utilized in conjunction with the Innovax vaccine by Merck Animal Health, which is used to safeguard poultry from bacterial infections.
The poultry segment is expected to lead the global veterinary vaccines market throughout the forecast period, expanding at a CAGR of 7.0%. The increased need for risk-free pet food, associated with a growing focus on developing new animal protection approaches, is estimated to drive the segment during the forecast period.
The injection segment is projected to retain the largest market share throughout the forecast period. Growth of the segment is attributable to increasing use of injection vaccines for protection of animal health. Injection vaccines play a crucial role in preventing and controlling the dissemination of disease outbreaks in both farm animals and livestock.
Throughout the forecast period, the inactivated segment is expected to dominate the market for veterinary vaccines. Inactivated vaccines are free from bacteria and suitable for rehabilitation, except in case of immunocompetent patients. These vaccines are usually compressed, which makes their shipping and preserving simple.
Due to growing prevalence of viral infections among livestock, including the Nipah virus infection, avian influenza, canine influenza, swine flu, and bird flu, the viral segment is expected to lead the market during the forecast period.
North America is expected to dominate the global market for veterinary vaccines during the forecast period, due to rising incidence of animal diseases and growing population of pets in the U.S.
Key market participants include Zoetis Inc., Bayer AG, Virbac SA, Merck KGaA, Eli Lilly and Company, Phibro Animal Health Corporation, Elanco Animal Health Incorporated, Aptimmune Biologics Inc., Dechra Pharmaceuticals PLC, and Laboratorios HIPRA, S.A.
You Can Download Free Sample PDF Copy of Veterinary Vaccines Market at About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Browse More Research Reports
Cold storage construction market:
Topical Drug Delivery Market:
Quantum Computing for Enterprise Market:
Industrial Nitrogen Market:
Construction Equipment Rental Market:
Radiation Therapy Quality Assurance (QA) Phantoms Market:
Next-Generation Biomanufacturing Market:
Cloud Backup & Recovery Market:
Artificial Intelligence (AI) in Food and Beverage Market:
Joint Reconstruction Market:
Internet of Things (IoT) Insurance Market:
8K Technology Market:
Robotics Surgical Simulation Systems Market:
Computer Aided Diagnostics (CAD) Market:
Advanced Prosthetics and Exoskeletons Market:
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: [email protected]
Facebook | LinkedIn | Twitter | Blogs